Effects of FUX on gemcitabine sensitivity in lung cancer cells
Lung cancer has accounted for the most deaths from cancer (19.2% of all cancer deaths) in registered cancer cases in New Zealand. At present lung cancer treatment is inadequate, as patients treated with the front-line drugs, such as gemcitabine, rapidly develop drug resistance by decreasing cellular...
| Main Author: | |
|---|---|
| Other Authors: | , |
| Format: | Others |
| Published: |
Auckland University of Technology,
2015-05-08T04:29:45Z.
|
| Subjects: | |
| Online Access: | Get fulltext |